articleThe LancetJul 1, 2002Closed access

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

7,008
total citations
FWCI
550.07
Percentile
100%
References
60
Citations per year

Authors

1

Topics & keywords

Keywords
  • Simvastatin
  • Medicine
  • Placebo
  • Internal medicine
  • Statin
  • Cholesterol
  • Diabetes mellitus
  • Cardiology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding